Portal de Periódicos da CAPES

Chemotherapeutics: antibiotics and other antimicrobials

2004; Wiley; Volume: 36; Issue: 1 Linguagem: Inglês

10.1111/j.1600-0757.2004.03677.x

1600-0757

Clay Walker, Katherine Karpinia, Pierre C. Baehni,

Antifungal resistance and susceptibility

Periodontology 2000Volume 36, Issue 1 p. 146-165 Chemotherapeutics: antibiotics and other antimicrobials Clay B. Walker, Clay B. WalkerSearch for more papers by this authorKatherine Karpinia, Katherine KarpiniaSearch for more papers by this authorPierre Baehni, Pierre BaehniSearch for more papers by this author Clay B. Walker, Clay B. WalkerSearch for more papers by this authorKatherine Karpinia, Katherine KarpiniaSearch for more papers by this authorPierre Baehni, Pierre BaehniSearch for more papers by this author First published: 25 August 2004 https://doi.org/10.1111/j.1600-0757.2004.03677.xCitations: 48Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Ashley RA. Clinical trials of a matrix metalloproteinase inhibitor in human periodontal disease. Ann NY Acad Sci 1999: 878: 335–346. 2 Axelsson P, Lindhe J. Effect of controlled oral hygiene procedures on caries and periodontal disease in adults. J Clin Periodontol 1978: 5: 133–151. 3 Axelsson P, Lindhe J. The significance of maintenance care in the treatment of periodontal disease. J Clin Periodontol 1981: 8: 281–294. 4 Axelsson P, Lindhe J, Nyström B. On the prevention of caries and periodontal disease: results of a 15-year longitudinal study in adults. J Clin Periodontol 1991: 18: 182–189. 5 Barbosa FCB, Mayer MPA, Saba-Chujfi E, Cai S. Subgingival occurrence and antimicrobial susceptibility of enteric rods and pseudomonads from Brazilian periodontitis patients. Oral Microbiol Immunol 2001: 16: 306–310. 6 Berglundh T, Krok L, Liljenberg B, Westfelt ESG, Lindhe J. The use of metronidazole and amoxicillin in the treatment of advanced periodontal disease. A prospective, controlled clinical trial. J Clin Periodontol 1998: 25: 354–362. 7 Binder TA, Goodson JM, Socransky SS. Gingival fluid levels of acid and alkaline phosphatase. J Periodontal Res 1987: 22: 14–19. 8 Blandizzi C, Malizia T, Lupetti A, Pesce D, Gabriele M, Giuca MR, Campa M, Del Tacca M, Senesi S. Periodontal tissue disposition of azithromycin in patients affected by chronic inflammatory periodontal diseases. J Periodontol 1999: 70: 960–966. 9 Britt MR, Pohlod DJ. Serum and crevicular fluid concentrations after a single oral dose of metronidazole. J Periodontol 1986: 57: 104–107. 10 Brooun A, Liu S, Lewis K. A dose–response study of antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 2000: 44: 640–646. 11 Caton JG, Ciancio SG, Blieden T, Bradshaw M, Crout RJ, Hefti AF, Massaro JM, Polson AM, Thomas J, Walker C. Subantimicrobial dose doxycycline as an adjunct to scaling and root planing: post-treatment effects. J Clin Periodontol 2001: 782–789. 12 Caton JG, Ciancio SG, Blieden T, Bradshaw M, Crout RJ, Hefti AF, Massaro JM, Polson AM, Thomas J, Walker C. Treatment with sub-antimicrobial dose doxycycline (Periostat®) improves the efficacy of scaling and root planing in patients with adult periodontitis. J Periodontol 2000: 71: 521–532. 13 Contreras A, Slots J. Mammalian viruses in human periodontitis. Oral Microbiol Immunol 1996: 11: 381–386. 14 Contreras A, Slots J. Herpesviruses in human periodontal disease. J Periodontal Res 2000: 35: 3–16. 15 Costerton JW. Introduction to biofilm. Int J Antimicrob Agents 1999: 11: 217–221. 16 Costerton JW, Cheng K-J, Geesey GG, Ladd TI, Nickel JC, Dasgupta M, Marrie TJ. Bacterial biofilms in nature and disease. Annu Rev Microbiol 1987: 41: 435–464. 17 Costerton JW, Cook G, Lamont R. The community architecture of biofilms. dynamic structures and mechanisms. In: Newman HN, Wilsom M. Dental Plaque Revisited. Cardiff: Bioline, 1999: 5–14. 18 Crout RJ, Lee HM, Schroeder K, Crout H, Ramamurthy NS, Wiener M, Golub LM. The 'cyclic' regimen of low-dose doxycycline for adult periodontitis: a preliminary study. J Periodontol 1996: 67: 506–514. 19 Daneshmand N, Jorgensen MG, Nowwzari H, Morrison JL, Slots J. Initial effect of controlled release chlorhexidine on subgingival microorganisms. J Periodontal Res 2002: 37: 375–379. 20 Drisko CL, Cobb CM, Killoy WJ, Michalowicz BS, Pihlstrom BL, Lowenguth RA, Caton JG, Encarnacion M, Knowles M, Goodson JM. Evaluation of periodontal treatments using controlled-release tetracycline fibers: clinical response. J Periodontol 1995: 66: 692–699. 21 Flemmig TF, Milián E, Karch H, Klaiber B. Differential clinical treatment outcome after systemic metronidazole and amoxicillin in patients harboring Actinobacillus actinomycetemcomitans and/or Porphyromonas gingivalis. J Clin Periodontol 1998: 25: 380–387. 22 Garrett S, Adams DF, Bogle G, Donly K, Drisko CH, Hallmon WW, Hancock EB, Hanes P, Hawley CE, Johnson L, Kiger R, Killoy W, Mellonig JT, Raab FJ, Ryder M, Stooler N, Polson A, Wang HL, Wolinsky LE, Yukna RA, Harrold CQ, Hill M, Johnson VB, Southard GL. The effect of locally delivered controlled-release doxycycline or scaling and root planing on periodontal maintenance patients over 9 months. J Periodontol 2000: 71: 22–30. 23 Garrett S, Johnson L, Drisko CH, Adams DF, Bandt C, Beiswanger B, Bogle G, Donly K, Hallmon WW, Hancock EB, Hanes P, Hawley CE, Kiger R, Killoy W, Mellonig JT, Polson A, Raab FJ, Ryder M, Stoller NH, Wang WL, Wolinsky LE, Even GH, Harrold CQ, Arnold RM, Southard GL. Two multi-center studies evaluating locally delivered doxycycline hyclate, placebo control, oral hygiene, and scaling and root planing in the treatment of periodontitis. J Periodontol 1999: 70: 490–503. 24 Golub LM, Goodson JM, Lee HM, Vidal AM, McNamara TF, Ramamurthy NS. Tetracyclines inhibit tissue collagenases. J Periodontol 1985: 56 (Suppl.): 93–97. 25 Golub LM, Lee HM, Greenwald RA, Ryan ME, Sorsa T, Salo T, Gainnobile WV. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm Res 1997: 46: 310–319. 26 Golub LM, Lee HM, Ryan ME, Giannobile WV, Payne J, Sorsa T. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res 1998: 12: 12–26. 27 Golub LM, McNamara TF, Ryan ME, Kohut B, Blieden T, Payonk G, Sipos T, Baron HJ. Adjunctive treatment with subantimicrobial doses of doxycycline: effects on gingival fluid collagenase activity and attachment loss in adult periodontitis. J Clin Periodontol 2001: 28: 146–156. 28 Golub LM, Sorsa T, Lee HM, Ciancio SSD, Ramamurthy NS, Gruber B, Salo T, Konttinen YT. Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva. J Clin Periodontol 1995: 22: 100–109. 29 Goodson JM. Pharmacokinetic principles controlling efficacy of oral therapy. J Dent Res 1989: 68: 1625–1632. 30 Gordon JM, Walker CB, Goodson JM, Socransky SS. Sensitive assay for measuring tetracycline levels in gingival crevice fluid. Antimicrob Agents Chemother 1980: 17: 193–198. 31 Gordon J, Walker C, Holiaras C, Socransky S. Efficacy of clindamycin hydrochloride in refractory periodontitis: 24-month results. J Periodontol 1990: 61: 686–691. 32 Gordon J, Walker C, Lamster I, West T, Socransky S, Seiger M, Fasciano R. Efficacy of clindamycin hydrochloride in refractory periodontitis: 12-months results. J Periodontol 1985: 56 (Suppl.): 75–80. 33 Gordon JM, Walker CB, Murphy JC, Goodson JM, Socransky SS. Tetracycline levels achievable in gingival crevice fluid and in vitro effect on subgingival organisms. Part I. Concentrations in crevicular fluid after repeated doses. J Periodontol 1980: 52: 609–612. 34 Greenstein G. Povidone-iodine's effects and role in the management of periodontal diseases: a review. J Periodontol 1999: 70: 1397–1405. 35 Griffiths GS, Smart GJ, Bulman JS, Weiss G, Shrowder J, Newman HN. Comparison of clinical outcomes following treatment of chronic adult periodontitis with subgingival scaling or subgingival scaling plus metronidazole gel. J Clin Periodontol 2000: 27: 910–917. 36 Gusberti FA, Syed SA, Lang NP. Combined antibiotic (metronidazole) and mechanical treatment effects on the subgingival bacterial flora of sites with recurrent periodontal disease. J Clin Periodontol 1988: 15: 353–359. 37 Haffajee AD, Dibart S, Kent RJ, Socransky SS. Clinical and microbiological changes associated with the use of 4 adjunctive systemically administered agents in the treatment of periodontal infections. J Clin Periodontol 1995: 22: 618–627. 38 Helldén LB, Listgarten MA, Lindhe J. The effect of tetracycline and/or scaling on human periodontal disease. J Clin Periodontol 1979: 6: 222–230. 39 Jeffcoat MK, Bray KS, Ciancio SG, Dentino AR, Fine DH, Gordon JM, Gunsolley JC, Killoy WJ, Lowenguth RA, Magnusson NI, Offenbacher S, Palcanis KG, Proskin HM, Finkelman RD, Flashner M. Adjunctive use of subgingival controlled-release chlorhexidine chip reduces probing depth and improves attachment level compared with scaling and root planing alone. J Periodontol 1998: 69: 989–997. 40 Joyston-Bechal S, Smales FC, Duckworth R. A follow up study 3 years after metronidazole therapy for chronic periodontal disease. J Clin Periodontol 1986: 13: 944–949. 41 Kleinfelder JW, Muller RF. Lange DE. Antibiotic susceptibility of putative periodontal pathogens in advanced periodontitis patients. J Clin Periodontol 1999: 26: 347–351. 42 Lacroix J-M, Walker CB. Characterization of a β-lactamase found in Eikenella corrodens. Antimicrob Agents Chemother 1991: 35: 886–891. 43 Lekovic V, Kenny EB, Carranza FAJ, Endres B. The effect of metronidazole on human periodontal disease. A clinical and bacteriological study. J Periodontol 1983: 54: 476–480. 44 Lindhe J. Treatment of localized juvenile periodontitis. In: RJ Genco, SE Mergenhagen, editors. Host–parasite Interactions in Periodontal Disease. Washington, DC: Am Soc Microbiol, 1981: 382–394. 45 Lindhe J, Liljenberg B, Adielson B. Effect of long-term tetracycline therapy on human periodontal disease. J Clin Periodontol 1983: 10: 590–601. 46 Listgarten MA, Lindhe J, Helldén L. Effect of tetracycline and/or scaling on human periodontal disease. J Clin Periodontol 1978: 5: 246–271. 47 Loesche WJ, Giodano JR, Hujoel P, Schwarcz J, Smith BA. Metronidazole in periodontitis. III. Reduced need for surgery. J Clin Periodontol 1992: 19: 103–112. 48 Loesche WJ, Giordano JR, Soehren S, Kaciroti N. The nonsurgical treatment of patients with periodontal disease: results after five years. J Am Dent Assoc 2002: 133: 311–320. 49 Loesche WJ, Schmidt E, Smith BA, Morrison EC, Caffesse R, Hujoel PP. Effects of metronidazole on periodontal treatment needs. J Periodontol 1991: 62: 247–257. 50 Loesche WJ, Schmidt E, Smith BA, Morrison EC, Caffesse R, Hujoel P. Metronidazole in periodontitis. II. Effect upon treatment needs. J Periodontol 1991: 62: 247–257. 51 Loesche WJ, Syed SA, Morrison EC, Kerry GA, Higgens T, Stoll J. Metronidazole in periodontitis. I. Clinical and bacteriological results after 15 and 30 weeks. J Periodontol 1984: 55: 325–335. 52 Lopez NJ, Gamonal JA, Martinez B. Repeated metronidazole and amoxicillin treatment of periodontitis: a follow-up study. J Periodontal 2000: 71: 79–89. 53 Madinier IM, Fosse TB, Hitzig C, Charbit Y, Hannoun LR. Resistance profile survey of 50 periodontal strains of Actinobacillus actinomycetemcomitans. J Periodontol 1999: 70: 888–892. 54 Magnusson I. The use of locally-delivered metronidazole in the treatment of periodontitis. Clinical results. J Clin Periodontol 1998: 25: 959–963. 55 Magnusson I, Clark WB, Low SB, Maruniak J, Marks RG, Walker CB. Effect of non-surgical periodontal therapy combined with adjunctive antibiotics in subjects with 'refractory' periodontal disease. J Clin Periodontol 1989: 16: 647–653. 56 Magnusson I, Clark WB, McArthur WP, Marks RG, Walker CB. Treatment of subjects with refractory periodontal disease. J Dent Res 1992: 72: (Abstr 1933). 57 Magnusson I, Clark WB, McArthur WP, Marks RG, Low SB, Walker CB, Maruniak J, Taylor M. Treatment of subjects with refractory periodontal disease. J Clin Periodontol 1994: 21: 628–637. 58 Magnusson I, Marks RG, Clark WB, Walker CB, Low SB, McArthur WP. Clinical, microbiological, and immunological characteristics of human subjects with 'refractory' periodontitis. J Clin Periodontol 1991: 18: 291–299. 59 McCulloch CAG, Birek P, Overall CM, Aitken S, Lee W, Kulkarni G. Randomized controlled trial of doxycycline in the prevention of recurrent periodontitis in high risk patients: antimicrobial activity and collagenase inhibition. J Clin Periodontol 1990: 17: 616–622. 60 Moore WEC, Holdeman LV, Cato EP. Bacteriology of moderate (chronic) periodontitis in mature adult humans. Infect Immun 1983: 42: 510–515. 61 Moore WEC, Ranney RR, Holdeman LV. Subgingival microflora in periodontal disease. In: RJ Genco, SE Mergenhagen, editors. Host–parasite Interactions in Periodontal Disease. Washington, DC: Am Soc Microbiol, 1982: 13–26. 62 Muller HP, Holderrieth S, Burkhardt U, Hoffler U. In vitro antimicrobial susceptibility of oral strains of Actinobacillus actinomycetemcomitans to seven antibiotics. J Clin Periodontol 2002: 736–742. 63 Muller HP, Lange DE, Muller RF. Failure of adjunctive minocycline-HCl to eliminate oral A. actinomycetemcomitans. J Clin Periodontol 1993: 20: 498–504. 64 Nakagawa T, Saito A, Hosaka Y, Yamada S, Tsunoda M, Sato T, Ishikawa T. Bactericidal effects on subgingival bacteria of irrigation with a povidone-iodine solution (Neo-jodin®). Bull Tokyo Dent Coll 1990: 31: 199–203. 65 Nangó S, Gollwitzer J, Sedlacek M, Walker C. Effect of antibiotics on subgingival plaque in a biofilm model. J Dent Res 2002: 81 (Abstr 1559). 66 Newman MG, Kornman KS, Doherty FM. A 6-month multi-center evaluation of adjunctive tetracycline fiber therapy used in conjunction with scaling and root planing in maintenance patients: clinical results. J Periodontol 1994: 65: 685–691. 67 Novak MJ, Polson AM, Adair SM. Tetracycline therapy in patients with early juvenile periodontitis. J Periodontol 1988: 59: 366–372. 68 Ohta Y, Okuda K, Takazoe I. Microbiological and clinical effects of systemic antibiotic administration in advanced periodontitis. Bull Tokyo Dent Coll 1986: 27: 139–148. 69 Oosterwaal PJ, Mikx FH, Renggli HH. Clearance of topically applied fluorescein gel from periodontal pockets. J Clin Periodontol 1990: 17: 613–615. 70 Pajukanta R. In vitro susceptibility of Porphyromonas gingivalis to azithromycin, a novel marcolide. Oral Microbiol Immunol 1993: 8: 325–326. 71 Pajukanta R, Asikainen S, Saarela M, Alaluusua S, Jousimies-Somer H. In vitro activity of azithromycin compared with that of erythromycin against Actinobacillus actinomycetemcomitans. Antimicrob Agents Chemother 1992: 36: 1241–1243. 72 Palmer RM, Matthews JP, Wilson RF. Non-surgical periodontal treatment with and without adjunctive metronidazole in smoker and non-smokers. J Clin Periodontol 1999: 26: 158–163. 73 Parra B, Slots J. Detection of human viruses in periodontal pockets using polymerase chain reaction. Oral Microbiol Immunol 1996: 11: 289–293. 74 Pascale D, Gordon J, Lamster I, Mann P, Seiger M, Arndt W. Concentrations of doxycycline in human gingival fluid. J Clin Periodontol 1986: 13: 841–844. 75 Pavicic MJAMP, van Winkelhoff AJ, Douqué NH, Steures RWR, DeGraaff J. Microbiological and clinical effects of metronidazole and amoxicillin in Actinobacillus actinomycetemcomitans-associated periodontitis. A 2-year evaluation. J Clin Periodontol 1994: 21: 107–112. 76 Poulet PP, Duffaut D, Lodter JP. Metronidazole susceptibility testing of anaerobic bacteria associated with periodontal disease. J Clin Periodontol 1999: 26: 161–263. 77 Purucker P, Mertes H, Goodson JM, Bernimoulin JP. Local versus systemic adjunctive antibiotic therapy in 28 patients with generalized aggressive periodontitis. J Periodontol 2001: 72: 1241–1245. 78 Quirynen M, Teughels W, De Soete M, Van Steenberghe D. Topical antiseptics and antibiotics in the initial therapy of chronic adult periodontitis: microbiological aspects. Periodontol 2000 2002: 28: 72–90. 79 Radvar M, Portaghi N, Kinane DF. Comparison of 3 periodontal local antibiotic therapies in persistent periodontal pockets. J Periodontol 1996: 67: 860–865. 80 Rams TE, Keyes PH. A rational for the management of periodontal diseases: effects of tetracycline on subgingival bacteria. J Am Dent Assoc 1983: 107: 37–41. 81 Riep B, Purucker P, Bernimoulin JP. Repeated local metronidazole-therapy as adjunct to scaling and root planing in maintenance patients. J Clin Periodontol 1999: 26: 710–715. 82 Rooney J, Wade WG, Sprague SV, Newcombe RG, Addy M. Adjunctive effects to non-surgical periodontal therapy of systemic metronidazole and amoxicillin alone and combined. A placebo controlled study. J Clin Periodontol 2002: 29: 342–350. 83 Rosling B, Hellstrom MK, Ramberg P, Socransky SS, Lindhe J. The use of PVP-iodine as an adjunct to non-surgical treatment of chronic periodontitis. J Clin Periodontol 2001: 28: 1023–1031. 84 Rosling BG, Slots J, Christersson LA, Gründahl HG, Genco RJ. Topical antimicrobial therapy and diagnosis of subgingival bacteria in the management of inflammatory periodontal disease. J Clin Periodontol 1986: 13: 975–981. 85 Rosling BG, Slots J, Webber RL, Christersson LA, Genco RJ. Microbiological and clinical effects of topical subgingival antimicrobial treatment on human periodontal disease. J Clin Periodontol 1983: 10: 487–514. 86 Saxén L, Asikainen S. Metronidazole in the treatment of localized juvenile periodontitis. J Clin Periodontol 1993: 20: 166–171. 87 Saxén L, Asikainen S, Kanervo A, Karl K, Jousimies-Somer H. The long-term efficacy of systemic doxycycline medication in the treatment of localized juvenille periodonititis. Arch Oral Biol 1990: 35 (Suppl.): 227S–229S. 88 Scopp IW, Froum SJ, Sullivan M, Kazandjian G, Wank D, Fine A. Tetracycline: a clinical study to determine its effectiveness in patients with chronic periodontal disease. J Periodontol 1980: 51: 328–390. 89 Sefton AM, Marskell P, Beighton D, Whiley A, Shain H, Foyle D, Smith SR, Smales FC, Williams JD. Azithromycin in the treatment of periodontal disease. Effect on microbial flora. J Clin Periodontol 1996: 23: 998–1003. 90 Skidmore R, Kovach R, Walker C, Thomas J, Bradshaw M, Leyden J, Powala C, Ashley R. Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne. Arch Dermatol 2003: 139: 459–464. 91 Slots J, Feik D, Rams TE. In vitro antimicrobial sensitivity of enteric rods and pseudomonads from advanced adult periodontitis. Oral Microbiol Immunol 1990: 5: 298–301. 92 Slots J, Feik D, Rams TE. Prevalence and antimicrobial susceptibility of Enterobacteriaceae, Pseudomonadaceae and Acinetobacter in human periodontitis. Oral Microbiol Immunol 1990: 5: 149–154. 93 Slots J, Mashimo P, Levine MJ, Genco RJ. Periodontal therapy in humans. I. Microbiological and clinical effects of a single course of periodontal scaling and root planing and of adjunctive tetracycline therapy. J Periodontol 1979: 50: 495–509. 94 Slots J, Rosling BJ. Suppression of the periodontopathic microflora in localized juvenile periodontitis by systemic tetracycline. J Clin Periodontol 1983: 10: 465–486. 95 Slots J, Ting M. Systemic antibiotic in the treatment of periodontal diseases. Periodontol 2000 2002: 28: 106–176. 96 Smith SR, Foyle DM, Daniels J, Joyston-Bechal S, Smales FC, Sefton A, Williams J. A double-blind, placebo-controlled trial of azithromycin as an adjunct to non-surgical treatment of periodontitis in adults: clinical results. J Clin Periodontol 2002: 29: 54–61. 97 Socransky SS, Haffajee AD. Dental biofilm: difficult therapeutic targets. Periodontol 2000 2002: 28: 12–55. 98 Söder B, Nedlich U, Jin LJ. Longitudinal effect of non-surgical treatment and systemic metronidazole for 1 week in smokers and non-smokers with refractory periodontitis: a 5-year study. J Periodontol 1999: 70: 761–771. 99 Söder PO, Frithiof L, Wikner S, Wouters FR, Nedlich V, Söder B, Rubin B. The effect of systemic metronidazole after non-surgical treatment in moderate and advanced periodontitis. J Periodontol 1990: 61: 281–288. 100 Soskolne WA, Heasman PA, Stabholz A, Smart GJ, Palmer M, Flashner M, Newman HN. Sustained local delivery of chlorhexidine in the treatment of periodontitis. J Periodontol 1997: 68: 32–38. 101 Stelzel M, Florès-de-Jacoby L. Topical metronidazole application as an adjunct to scaling and root planing. J Clin Periodontol 2000: 27: 447–452. 102 Stelzel M, Florès-de-Jacoby L. Topical metronidazole application compared with subgingival scaling. J Clin Periodontol 1996: 23: 24–29. 103 Stelzel M, Florès-de-Jacoby L. Topical metronidazole application in recall patients. Long-term results. J Clin Periodontol 1997: 24: 914–919. 104 Stickler D. Biofilms. Curr Opin Microbiol 1999: 2: 270–275. 105 Stoller NH, Johnson LR, Trapnell S, Harrold CQ, Garrett S. The pharmacokinetic profile of a biodegradable controlled-release delivery system containing doxycycline compared to systemically delivered doxycycline in gingival crevicular fluid, saliva, and serum. J Periodontol 1998: 69: 1085–1091. 106 Stolze K, Stellfeld M. Systemic absorption of metronidazole after application of a 25% metronidazole dental gel. J Clin Periodontol 1992: 19: 693–697. 107 Tenenbaum H, Jehl F, Gallion C, Dahan M. Amoxicillin and clavulanic acid concentrations in gingival crevicular fluid. J Clin Periodontol 1997: 24: 804–807. 108 Thomas J, Walker C. Long-term use of subantimicrobial dose doxycycline does not lead to changes in antimicrobial susceptibility. J Periodontol 2000: 71: 1472–1483. 109 Thomas JG, Metheny RJ, Karakiozis JM, Wetzel JM, Crout RJ. Long-term sub-antimicrobial doxycycline (Periostat) as adjunctive management in adult periodontitis: effects on subgingival bacterial population dynamics. Adv Dent Res 1998: 12: 32–39. 110 Ting MM, Contreras A, Slots J. Herpesviruses in localized juvenille periodontitis. J Periodontal Res 2000: 35: 17–25. 111 Tinoco EM, Beldi MI, Campedelli F, Lana M, Loureiro CA, Bellini HT, Rams TE, Tinoco NM, Gjermo P, Preus HR. Clinical and microbiological effects of adjunctive antibiotics in treatment of localized juvenile periodontitis. A controlled clinical trial. J Periodontol 1998: 69: 1355–1363. 112 Van Oosten MA, Notten FJ, Mikx FH. Metronidazole concentrations in human plasma, saliva, and gingival crevice fluid after a single dose. J Dent Res 1986: 65: 1420–1423. 113 Van Winkelhoff AJ, Rodenburg JP, Goene RJ, Abbas F, Winkel EG, DeGraaf J. Metronidazole plus amoxicillin in the treatment of Actinobacillus actinomycetemcomitans associated periodontitis. J Clin Periodontol 1989: 16: 128–131. 114 Van Winkelhoff AJ, Tijhof CJ, De Graaff J. Microbiological and clinical results of metronidazole plus amoxicillin therapy in Actinobacillus actinomycetemcomitans associated periodontitis. J Periodontol 1992: 63: 52–57. 115 Van Winkelhoff AJ, Vangsted T, Winkel EG. Metronidazole in the treatment of refractory periodontitis. Ned Tijdschr Tandheelkd 2000: 107: 327–331. 116 Walker C, Gordon J. The effect of clindamycin on the microbiota associated with refractory periodontitis. J Periodontol 1990: 61: 692–698. 117 Walker C, Nangó S, Lennon J, Yu C, Preshaw P, Hefti A, Novak J, Powala C. Effect of sub-antimicrobial dose doxycycline (SDD) on intestinal and vaginal flora. J Dent Res 2000: 79: 608 (Abstr 3718). 118 Walker C, Sedlacek M, Nangó S, Gollwitzer J. An in vitro biofilm model of subgingival plaque. J Dent Res 2002: 81: 90 (Abstr 1450). 119 Walker C, Sedlacek M, Nango S, Gollwitzer J, Michalski S. An oral biofilm model for the study of antibiotic susceptibilities. J Dent Res 2001: 80: 696 (Abstr 1353). 120 Walker C, Thomas J, Nangó S, Lennon J, Wetzel J, Powala C. Long-term treatment with sub-antimicrobial dose doxycycline exerts no antibacterial effect on the subgingival microflora associated with adult periodontitis. J Periodontol 2000: 71: 1465–1471. 121 Walker CB. The acquisition of antibiotic resistance in the periodontal microflora. Periodontol 2000 1996: 10: 79–88. 122 Walker CB, Godowski KC, Borden L, Lennon J, Nangó S, Stone C, Garrett S. The effects of sustained release doxycycline on the anaerobic flora and antibiotic-resistant patterns in subgingival plaque and saliva. J Periodontol 2000: 71: 768–774. 123 Walker CB, Gordon JM, Corwall HA, Murphy JC, Socransky SS. Gingival crevicular fluid levels of clindamycin compared with its minimal inhibitory concentration for periodontal bacteria. Antimicrob Agents Chemother 1981: 19: 867–871. 124 Walker CB, Gordon JM, Magnusson I, Clark WB. A role for antibiotics in the treatment of refractory periodontitis. J Periodontol 1993: 64 (Spec iss): 772–781. 125 Walker CB, Gordon JM, McQuilkin SJ, Niebloom TA, Socransky SS. Tetracycline: Levels achievable in gingival crevice fluid and in vitro effect on subgingival organisms. Part II. Susceptibilities of periodontal bacteria. J Periodontol 1981: 52: 613–616. 126 Walker CB, Gordon JM, Socransky SS. Antibiotic susceptibility testing of subgingival plaque samples. J Clin Periodontol 1983: 10: 422–432. 127 Walker CB, Niebloom TA, Gordon JM, Socransky SS. In vitro susceptibilities of bacteria from human periodontal pockets to 13 antimicrobial agents. In: Nelson JD, Grassi C. Current Chemotherapy and Infectious Disease, Vol. 1. Washington, D.C.: American Society for Microbiology, 1980: 508–511. 128 Walker CB, Pappas JD, Tyler KZ, Cohen S, Gordon JM. Antibiotic susceptibilities of periodontal bacteria. In vitro susceptibilities to eight antimicrobial agents. J Periodontol 1985: 56 (Suppl.): 67–74. 129 Walker CB, Tyler KT, Low SB, King CJ. Penicillin-degrading enzyme in sites associated with adult periodontitis. Oral Microbiol Immunol 1987: 2: 129–131. 130 Williams RC, Paquette DW, Offenbacher S, Adams DF, Armitage GC, Bray K, Caton J, Cochran DL, Drisko CH, Fiorellini JP, Giannobile WV, Grossi S, Guerrero DM, John GK, Lamster IB, Magnusson I, Oringer RJ, Persson GR, Van Dyke TE, Wolff LF, Santucci EA, Rodda BE, Lessem J. Treatment of periodontitis by local administration of minocycline microspheres: a controlled trial. J Periodontol 2001: 72: 1535–1544. 131 Winkel EG, Van Winkelhoff AJ, Barendregt DS, Van Der Weijden GA, Timmerman MF, Van Der Velden U. Clinical and microbial effects of initial periodontal therapy in conjunction with amoxicillin and clavulanic acid in patients with adult periodontitis. A randomised double-blind, placebo-controlled study. J Clin Periodontol 1999: 26: 461–468. 132 Winkel EG, Van Winkelhoff AJ, Timmerman MF, Van Der Velden U, Van Der Weijden CA. Amoxicillin plus metronidazole in the treatment of adult periodontitis patients. A double-blind, placebo-controlled study. J Clin Periodontol 2001: 28: 296–305. 133 Winkel EG, Van Winkelhoff AJ, Timmerman MF, Vangsted T, Van Der Velden U. Effects of metronidazole in patients with 'refractory' periodontitis associated with Bacteroides forsythus. J Clin Periodontol 1997: 24: 573–579. 134 Winkel EG, Van Winkelhoff AJ, Van Der Velden U. Additional clinical and microbiological effects of amoxicillin and metronidazole after initial periodontal therapy. J Clin Periodontol 1998: 25: 857–865. 135 Wong MY, Lu CL, Liu CM, Hou LT, Chang WK. Clinical response of localized recurrent periodontitis treated with scaling, root planing, and tetracycline fiber. J Formos Med Assoc 1998: 97: 490–497. Citing Literature Volume36, Issue1October 2004Pages 146-165 ReferencesRelatedInformation